RedChip Drops Research Coverage on Nutrition 21
Posted on: Tuesday, 12 February 2008, 15:00 CST
ORLANDO, Fla., Feb. 12, 2008 (PRIME NEWSWIRE) -- RedChip Independent, a division of RedChip Companies Inc. today announced that it has dropped research coverage on Nutrition 21 Inc. (Nasdaq:NXXI).
RedChip Companies' initial rating of a "Strong Buy" and a target price of $3.64, and a recent rating of "Buy" and a target price of $3.78, are no longer active. For further information on RedChip Companies, our "rating" system, and our dropping coverage policy, please visit www.redchip.com and review any and all pertinent policies and disclosures.
About Nutrition 21, Inc.
Nutrition 21, Inc., headquartered in Purchase, New York, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness brands include: Chromax(r), Core4Life Advanced Memory Formula, Diabetes Essentials, Iceland Health(r) Maximum Strength Omega-3 and Iceland Health(r) Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 29,000 major food, drug and super center retailers as well as internationally. For more information please visit http://www.nutrition21.com
About RedChip Companies, Inc.
RedChip Companies is an international small-cap research and financial public relations firm with offices in Beijing and Orlando and affiliates in New York and San Diego. RedChip delivers measurable results for its clients through its extensive international market expertise as well as its comprehensive platform of products: RedChip Research, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences held throughout the United States, RedChip Radio and RedChip Visibility Research Program services. To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/services.asp
"Discovering Tomorrow's Blue Chips Today."(tm)
RedChip Independent Research Disclosure
The analysts contributing to this NXXI RedChip report do not hold any shares of NXXI. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the NXXI RedChip report. Additional information on the securities mentioned in the reports is available upon request. This NXXI RedChip equity research report is based on data obtained from sources we believe to be reliable but is not guaranteed as to accuracy and is not purported to be complete. As such, the NXXI RedChip report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed therein are subject to change. NXXI is not a client of RedChip Companies, Inc., or any of its affiliates.
This news release was distributed by PrimeNewswire, www.primenewswire.com
CONTACT: RedChip Companies 1-800-REDCHIP (733-2447) info@redchip.com www.redchip.com
Source: PrimeNewswire
Related Articles
- Gordian Health Solutions, Inc. Named Leading Wellness Vendor By Health Industries Research Companies
- More Companies Offering Consumer-Directed Health Plans, Watson Wyatt/National Business Group on Health Survey Finds
- NutriOne Announces It Has Concluded Its Agreement With Research in Nutrition and Nutraceuticals (RINN)
- Healtheva's Social Bookmarking Tools Simplify the Sharing of Medical and Health Related Content and Improve the Online Search Experience for Physicians and Life Science Researchers
- Supplement Use Is Associated With Health Status and Health-Related Behaviors in the 1946 British Birth Cohort1-3
- New Study Shows Significant Improvements in Health-Related Quality-of-Life Measures in Chronic Obstructive Pulmonary Disease Patients Using SPIRIVA(R) HandiHaler(R)
- Innovative Health Research Company Fills Void in Marketplace
- Award-Winning, Animated Guide on Nutrition and Eye Health Now Available Online From ScienceBased Health
- Cilansetron Improves Health Related Quality of Life in Multinational Phase III Clinical Trial Patients With Irritable Bowel Syndrome With Diarrhea Predominance (IBS-D)
 |
 |
User Comments (0)
RSS Feeds